![]() Sarepta Therapeutics Sarepta Therapeutics is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapeutics, gene therapy and, other genetic therapeutic modalities for the treatment of rare diseases. | ||
Founding Date | Founding Date 1980 | Founding Date 1992 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Cambridge, US HQ Dublin, IE Zug, CH Providence, US | Locations Somerville, US HQ |
Employees | Employees 1,31413% increase | Employees 32338% decrease |
Valuation ($) | Valuation ($) 12.4 b | Valuation ($) 95.4 m |
Financial | ||
Revenue (est.) | Revenue (est.) $2.2b (FY, 2025) | Revenue (est.) $83.8m (FY, 2024) |
Cost of goods | Cost of goods $25.5m (FY, 2025) | Cost of goods $89.4m (FY, 2024) |
Gross profit | Gross profit $2.2b (FY, 2025) | Gross profit ($5.6m) (FY, 2024) |
Net income | Net income ($713.4m) (FY, 2025) | Net income ($240.7m) (FY, 2024) |

Bluebird Bio is a developer of gene therapies for severe genetic diseases.
View company